Ken-Ichi Shibasaki

Ken-Ichi Shibasaki

Auto-generated profile, based on publicly available information

Ken-Ichi Shibasaki

Department of Virology I, National Institute of Infectious Diseases, Tokyo 162-8640, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2021 in Viruses
Verified
Journal Article
Open access
PDF file
ENEri Nakayama
Eri Nakayama
YKYasuhiro Kawai
Yasuhiro Kawai
STSatoshi Taniguchi
Satoshi Taniguchi
JHJessamine Hazlewood
Jessamine Hazlewood
KSKen-Ichi Shibasaki
Ken-Ichi Shibasaki
MSMasayuki Saijo
Masayuki Saijo
Zika virus (ZIKV) infection during pregnancy causes a wide spectrum of congenital abnormalities and postnatal developmental sequelae such as fetal loss, intrauterine growth restriction (IUGR), microcephaly, or motor and neurodevelopmental disorders. Here, we investigated whether a mouse pregnancy model recapitulated a wide range of symptoms after congenital ZIKV infection, and whether the embryonic age of congenital infection changed the fetal or postnatal outcomes. Infection with ZIKV strain PRVABC59 from embryonic day 6.5 (E6.5) to E8.5, corresponding to the mid-first trimester in humans, caused fetal death, fetal resorption, or severe IUGR, whereas infection from E9.5 to E14.5, corresponding to the late-first to second trimester in humans, caused stillbirth, neonatal death, microcephaly, and postnatal growth deficiency. Furthermore, 4-week-old offspring born to dams infected at E12.5 showed abnormalities in neuropsychiatric state, motor behavior, autonomic function, or reflex and sensory function. Thus, our model recapitulated the multiple symptoms seen in human cases, and the embryonic age of congenital infection was one of the determinant factors of offspring outcomes in mice. Furthermore, maternal neutralizing antibodies protected the offspring from neonatal death after congenital infection at E9.5, suggesting that neonatal death in our model could serve as criteria for screening of vaccine candidates.